Literature DB >> 23457162

Nonsmall cell lung cancer.

Jean-Paul Sculier1.   

Abstract

The objective of this review is to report the Clinical Year in Review proceedings in the field of nonsmall cell lung cancer that were presented at the 2012 European Respiratory Society Congress in Vienna, Austria. Various topics were reviewed, including epidemiology, screening, diagnosis, treatment, prognosis, and palliative and end of life care.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457162     DOI: 10.1183/09059180.00007012

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  10 in total

Review 1.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

2.  Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance.

Authors:  Zhanzhao Fu; Guogui Sun; Tao Gu
Journal:  Tumour Biol       Date:  2013-11-23

3.  The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.

Authors:  Jing Liu; Li Wan; Kaihua Lu; Ming Sun; Xuan Pan; Ping Zhang; Binbin Lu; Guojian Liu; Zhaoxia Wang
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

4.  Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells.

Authors:  James Lawson; Christopher Dickman; Sara MacLellan; Rebecca Towle; James Jabalee; Stephen Lam; Cathie Garnis
Journal:  Oncotarget       Date:  2017-08-07

5.  The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis.

Authors:  Yun Zhao; Jianbo He; Shaozhang Zhou; Ruiling Ning; Wenhua Zhao; Huilin Wang; Cuiyun Su; Wei Jiang; Xiaoning Zhong; Qitao Yu
Journal:  Comput Math Methods Med       Date:  2022-09-07       Impact factor: 2.809

6.  Patient outcomes post-pulmonary resection for synchronous bone-metastatic non-small cell lung cancer.

Authors:  Yuki Takahashi; Hirofumi Adachi; Yasushi Mizukami; Hiroshi Yokouchi; Satoshi Oizumi; Atsushi Watanabe
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

7.  Inhibition of SENP1 induces radiosensitization in lung cancer cells.

Authors:  Ruo-Tian Wang; Xiu-Yi Zhi; Yi Zhang; Jian Zhang
Journal:  Exp Ther Med       Date:  2013-08-08       Impact factor: 2.447

8.  Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer.

Authors:  Jun Li; Zhenhua Wang; Kai Mao; Xixi Guo
Journal:  Oncol Lett       Date:  2014-07-29       Impact factor: 2.967

9.  Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.

Authors:  Shize Yang; Siyuan Dong; Xiaohan Qu; Xinwen Zhong; Qigang Zhang
Journal:  Mol Med Rep       Date:  2016-12-13       Impact factor: 2.952

10.  Histological subtype of lung cancer affects acceptance of illness, severity of pain, and quality of life.

Authors:  Jacek Polański; Mariusz Chabowski; Beata Jankowska-Polańska; Dariusz Janczak; Joanna Rosińczuk
Journal:  J Pain Res       Date:  2018-04-10       Impact factor: 3.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.